SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-19-019545
Filing Date
2019-04-12
Accepted
2019-04-12 17:00:30
Documents
5
Period of Report
2019-05-30
Effectiveness Date
2019-04-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT tv518711-def14a.htm DEF 14A 409246
2 GRAPHIC lg_protalix.jpg GRAPHIC 25457
3 GRAPHIC sig_yossi-maimon.jpg GRAPHIC 9221
4 GRAPHIC tv518711_pc1.jpg GRAPHIC 501173
5 GRAPHIC tv518711_pc2.jpg GRAPHIC 780075
  Complete submission text file 0001144204-19-019545.txt   2222867
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33357 | Film No.: 19746893
SIC: 2836 Biological Products, (No Diagnostic Substances)